Pliant Therapeutics Inc

NASDAQ:PLRX  
28.22
-0.04 (-0.14%)
Earnings Announcements

Pliant Therapeutics Reports Q3 2020 Financial Results

Published: 11/10/2020 21:18 GMT
(PLRX) - Pliant Therapeutics Provides Corporate Update and Reports Third Quarter 2020 Financial Results.
Qtrly Loss per Share $0.47.
As of September 30, 2020, Pliant Had Cash, Cash Equivalents and Short-term Investments of $294.0 Million.
Believes It Has Sufficient Funds to Meet Its Operating and Capital Requirements Into 2023.
Q3 Earnings per Share View $-0.85 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $3.37 Million
Adjusted EPS is expected to be -$0.71

Next Quarter Revenue Guidance is expected to be $3.25 Million
Next Quarter EPS Guidance is expected to be -$0.66

More details on our Analysts Page.